Predictive value of DOT1L mutations for clinical outcomes in non-small-cell lung cancer patients receiving immune checkpoint inhibitor therapy.

ABSTRACT:

SUBMITTER: Guo T 

PROVIDER: S-EPMC10545889 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature